Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $96.1 million.

  • MDxHealth's Non-Current Assets rose 1014.17% to $96.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.1 million, marking a year-over-year increase of 1014.17%. This contributed to the annual value of $90.4 million for FY2024, which is 59.03% down from last year.
  • According to the latest figures from Q3 2025, MDxHealth's Non-Current Assets is $96.1 million, which was up 1014.17% from $101.9 billion recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Non-Current Assets ranged from a high of $101.9 billion in Q2 2025 and a low of $8.5 million during Q4 2021
  • Over the past 5 years, MDxHealth's median Non-Current Assets value was $90.0 million (recorded in 2024), while the average stood at $6.9 billion.
  • Per our database at Business Quant, MDxHealth's Non-Current Assets plummeted by 341.13% in 2021 and then skyrocketed by 11317604.8% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's Non-Current Assets stood at $8.5 million in 2021, then soared by 962.91% to $90.0 million in 2022, then grew by 1.09% to $91.0 million in 2023, then decreased by 0.59% to $90.4 million in 2024, then rose by 6.22% to $96.1 million in 2025.
  • Its last three reported values are $96.1 million in Q3 2025, $101.9 billion for Q2 2025, and $88.5 million during Q1 2025.